PATENT CLAIM ANALYSIS

Application Number: 16154333
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-10
Patent Classification: ["424", "085400"]

Abstract:
A method for inducing a sustained immune response in humans or animal patient suffering from human immunodeficiency virus (HIV) acquired immune deficiency syndrome (AIDS, autoimmune disease, cancer, inflammation, and neurodegenerative diseases comprises daily administration to such patients a single oral tablet, rapidly dissolving film, capsule, liquid or cream dose of an Immediate release naltrexone composition comprising between about 0.01 to about 10 mg of naltrexone. In order to provide a benefit the naltrexone must be an Immediate release composition comprising between about 0.01 and about 10 mg of naltrexone

Claim (Index 8):
The method of  claim 1 , wherein said mammal is a human.

Metadata:
- Claim Count in Document: 19.0
- Percentile: 97.0
- Lexical Diversity: 1.44928
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15437365', '13764543', '12995126', '15101878', '15950606']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7113247022161365
- 35 USC 102 Novelty (BERT): 0.5188579213729971
- Combined Prediction Score: 0.6920780241318226
- Mean Citation Score: 226.475172
- Max Citation Score: 322.87463
- Similarity Product: 269.87031405348483

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test